Steven Bulera, PhD profile page

Dr. Steven Bulera, DABT, has over 25 years in the pharmaceutical industry. He is currently the global head of toxicology at Charles River Laboratories, having served as the head of toxicology at both the Shrewsbury (Massachusetts) and Reno (Nevada) sites since 2007. Bulera holds degrees in biochemistry from Canisius College (BA) and the University of Connecticut (MSc/PhD). Prior to Charles River, Bulera held positions at three pharmaceutical companies: Parke-Davis, Pfizer, and Bristol-Myers Squibb. He has experience as an in vivo study director, has been the head of genetic toxicology, and has led an investigational toxicology group with experience in the panomic technologies (toxicogenomics, proteomics and, metabolomics). Bulera also has experience in drug development and has worked on numerous drug candidates being developed for oncology and anti-HIV therapies. He was a postdoctoral fellow in Dr. Henry Pitot’s laboratory at the McArdle Laboratory for Cancer Research at the University of Wisconsin. He is a current member of the American College of Toxicology and the Society of Toxicology. Bulera has been a diplomat of the American Board of Toxicology since 1998.